Suppression of nitric oxide production by osteopontin

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424 855, 4242781, 530351, 530330, 530326, 530300, 514 2, 514 12, A01N 3718, A61K 3800, A61K 3938, C07K 200

Patent

active

056957610

ABSTRACT:
The present invention relates to compositions and methods for inhibition of the vasoactive and signal transduction agent nitric oxide (NO), and to therapeutic treatment of diseases or disorders that involve inappropriate or detrimental NO activity. The invention particularly relates to modulation of kidney function. In specific embodiments, osteopontin and a 20-amino acid fragment of osteopontin that contains an Arg-Gly-Asp sequence suppress expression of inducible NO synthase mRNA, and osteopontin suppresses the activity of constitutive NO synthase.

REFERENCES:
patent: 5049659 (1991-09-01), Cantor et al.
patent: 5281627 (1994-01-01), Griffiths
patent: 5312835 (1994-05-01), Kilbourn et al.
Denhardt and Guo, 1993, FASEB J. 7:1475-82.
Goureau et al., 1993, Proc. Natl. Acad. Sci. U.S.A. 90:4276-80.
Ignarro et al., 1993, Proc. Natl. Acad. Sci. U.S.A. 90:8103-07.
Lopez et al., 1993, Lab. Invest. 69:355.
Markewitz et al., 1993, J. Clin. Invest. 91:2138-2143.
Zimolo et al., 1994, Am. J. Physiol. :C376-80.
Chambers et al., 1992, Anticancer Res. 12:43-48.
Heck et al., 1992, J. Biol. Chem. 267:21277-80.
Lyons, 1992, J. Biol. Chem. 267:6370-74.
McCall et al., 1992, Biochem. Biophys. Res. Commun. 186:680-685.
Punjabi, et al., 1992, J. Immunol., 149:2179-84.
Nathan, 1992, FASEB J. 6:3051-64.
Stoos et al., 1992, J. Clin. Invest. 89:761-765.
Wilcox et al., 1992, Proc. Natl. Acad. Sci. USA 89:11993-97.
Ishii et al., 1991, J. Pharmacol. Exp. Therap. 256:38-43.
Miyanchi et al., 1991, J. Biol. Chem. 266:20369-74.
Ding et al., 1990, J. Immunol. 145:940-44.
Craig et al., 1989, J. Biol. Chem. 264:9682-9.
Khokha and Denhardt, 1987, Anticancer Res. 7:653-660.
Oldberg et al., 1986, Proc. Natl. Acad. Sci. U.S.A., 83:8819-23.
Oliphant et al., 1986, Gene 44:177.
Green et al., 1982, Analytical Biochem. 126:131-138.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Suppression of nitric oxide production by osteopontin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Suppression of nitric oxide production by osteopontin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of nitric oxide production by osteopontin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1605580

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.